News About: Pharm. Industry
Handok will be reborn as health innovator
Under the spirit of ‘The Health Innovator’ this year despite economic downturn, Handok will continue to expand its presence in the domestic market through joint development of new products and licensing with advanced ...
Korean antihypertensive drugs increase market share
Korean-made antihypertensive drugmakers have taken up bigger share in the final quarter of last year, an industry report showed recently.
According to UBIST data, Chong Kun Dang Pharmaceutical’s Salotan (losartan) ...
Multinational firms back FTC action over undue rebates
The Korean Research-based Pharmaceutical Industry Association (KRPIA) said on January 16 that it has supported the Fair Trade Commission’s action to root out illicit practices, adding this should serve as a catalyst t...
Concerns grow over re-assessment of drug economic effectiveness
The Health Insurance Review and Assessment Service plans to evaluate the economic effectiveness of 3,000-odd medicines covered by national health insurance, including leading antihypertensive agents, this year, trigge...
Hanmi sales increased 10% in 2008
Hanmi Pharm’s sales increased 10 percent last year as the company saw 11 products exceed 10 billion won.
Those involved are Amordipin, antihypertensive agent (57 billion won); Medilac, preparations for intestinal f...
Boryung eager to license out novel angiotensin II receptor antagonist
With its new angiotensin II receptor blocker, Fimasartan, Boryung Pharm is seeking partners that can progress further clinical trial and market in US or EU in the future.
Fimasartan is a novel, non-peptide angioten...
Japanese health authorities approves concurrent therapy of Fastic
Tokyo-headquartered pharmaceutical company, Astellas announced that an additional indication for nateglinide, has been recently approved in Japan, according to Ildong Pharm.
Nateglinide is a fast-acting postprandia...
Hanmi seeking to minimize erroneous dispensing at pharmacy
Hanmi Pharm has rolled its sleeves to prevent the possible erroneous dispensing at pharmacy.
The company said it plans to supply newly launched medicine, including Slimmer capsule, to pharmacies with four different...
Daewoong vice chairman named 'Entrepreneur of the Year'
Yoon Jae-seung, chairman of Daewoong Pharmaceutical Co., has named the Rising Star Entrepreneur of the Year in a business award for entrepreneurs in recognition of his efforts to transform a pharmaceutical company int...
Restructuring is key word for multinational firms
Restructuring is a key word for a number of foreign invested pharmaceutical firms, under the government's pressure to lower drug costs following the new drug pricing policy, so-called positive list system, and without...
